Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Silexion Therapeutics Corp (SLXN)

Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Silexion Therapeutics Corp 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 ISR

www.silexion.com Employees: 14 P: 972-3756-4999

Sector:

Medical

Description:

Silexion Therapeutics Ltd. is a pioneering clinical stage, oncology-focused biotechnology company dedicated to the development of innovative treatments for unsatisfactorily treated solid tumor cancers which have the mutated KRAS oncogene, generally considered to be the most common oncogenic gene driver in human cancers. Silexion Therapeutics Ltd., formerly known as Biomotion Sciences, is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 5,197
Enterprise Value, $K 6,937
Shares Outstanding, K 3,127
Float, K 2,483
% Float 79.40%
Short Interest, K 56
Short Float 1.78%
Days to Cover 1.68
Short Volume Ratio 0.66
% of Insider Shareholders 20.60%
% of Institutional Shareholders 10.95%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -16,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,260 K
EBIT, $ -11,310 K
EBITDA, $ -11,280 K

Growth:

1-Year Return -89.79%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.88 on 11/12/25
Next Earnings Date 03/17/26 [--]
Earnings Per Share ttm -11.10
EPS Growth vs. Prev Qtr 33.33%
EPS Growth vs. Prev Year 98.95%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 07/29/25

SLXN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -649.60%
Return-on-Assets % -129.41%
Profit Margin % 0.00%
Debt/Equity 0.22
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.78
Book Value/Share 2.23
Interest Coverage -3.19
60-Month Beta -0.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar